tradingkey.logo
tradingkey.logo
Search

Brainsway Ltd

BWAY
Add to Watchlist
15.030USD
-1.290-7.90%
Close 05/15, 16:00ETQuotes delayed by 15 min
588.66MMarket Cap
32.77P/E TTM

Brainsway Ltd

15.030
-1.290-7.90%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-7.90%

5 Days

-12.46%

1 Month

-1.96%

6 Months

-4.63%

Year to Date

-20.98%

1 Year

+51.66%

TradingKey Stock Score of Brainsway Ltd

Currency: USD Updated: 2026-05-15

Key Insights

Brainsway Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 93 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 15.33.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Brainsway Ltd's Score

Industry at a Glance

Industry Ranking
93 / 206
Overall Ranking
217 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Brainsway Ltd Highlights

StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 64.31% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 52.23M.
Fairly Valued
The company’s latest PE is 32.77, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.27M shares, decreasing 20.62% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 553.72K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.64.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
15.333
Target Price
-6.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Brainsway Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Brainsway Ltd Info

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOLevy (Hadar)
Websitehttps://www.brainsway.com/
KeyAI